Charles Jolley

Buy, Build, Refactor | Founder @ Tinman Group

[Charles Jolley @okito]

New from @TinmanGroup - Why AI Won't Take Your Job in 12 Months (the diffusion rate problem no one is talking about)
https://t.co/VYmieIM26M

[Charles Jolley @okito]

The Tinman Manifesto - our view on the future of tech investing and where AI will really make a difference.
https://t.co/jatoDW0Ars

[Charles Jolley @okito]

Evidently Trump figured out that promising something in two weeks is short enough to get people off your back but long enough they will forget about it and move on.

Every time he says something is coming in two weeks it’s a stall. Always. Easiest tell and amazing that it works still.

Anyway, planning a bigger story on this. Major breaking news. Expect it in about two weeks.

[Charles Jolley @okito]

@antoniogm Dunning-Kruger disease?

[David Dripps @daviddripps]

There were too many insights to share in a single thread, so here are my key takeaways from Day 2 of HoldCoConf. I’ll also be posting my (much shorter) takeaways from Day 3 later today.
If you run a small business and are serious about scaling through acquisition, make @HoldCoConf a non-negotiable in 2026.
#HoldCo #SMBTwitter #AcquisitionEntrepreneurship

[Nivoda @nivoda]

New U.S. tariffs take effect this April - Nivoda is actively managing pricing, supply chain stability, and real-time updates to keep you informed and supported.
#tariffs #USTariffs #TariffImpact

[Charles Jolley @okito]

Economics reality check: Today's 14% import reliance vs 1930s' 3-5% doesn't mean new tariffs = Smoot-Hawley 2.0. Our 80% service economy has different vulnerabilities than our manufacturing-dominant past. Still concerning, but requires nuanced planning, not panic.

[Charles Jolley @okito]

@robleclerc As it has been since the dawn of AI time (ie 1950)

[Nivoda @nivoda]

We are excited to announce Nivoda has been selected as a finalist in the Jewellery Industry Supplier of the Year category at the Professional Jeweller Awards 🥳

#PJAwards #JewelleryAwards #ProfessionalJeweller

[Charles Jolley @okito]

Alignment (wanting the same thing) is far more important than agreement (doing the same thing) if you want to scale your team. Josh Broward at Wisdom Partners explains how to get there.

https://t.co/SYvYY3Ov9Z

[Charles Jolley @okito]

Excited for @nivoda - it’s been great to be on the journey eh then as they transform global jewelry trade for the better

[Nivoda @nivoda]

We are thrilled to announce that Nivoda has secured $30m in Series B funding, led by Avenir Growth Capital 💎🚀

https://t.co/BHlkSmvu4U

[Matt Clifford @matthewclifford]

I was saying to friends that the ad would be so much better in reverse… and someone pointed out that @rezawrecktion did it and it actually is!

[Charles Jolley @okito]

Congrats to the @KheironMedical team. All those award ceremonies must be getting a little old…

[Kheiron @KheironMedical]

While it's great to get international recognition for our work, what really makes us happy is knowing that Mia® is finding 12-15% more breast cancers in the UK and Europe. #jobsatisfaction

https://t.co/TqoLKDTlmg

[Charles Jolley @okito]

@ChrisHarveyEsq It is better for employees if your 409 a valuation is low. Therefore, if you raise money, you first have to convince investors why you’re worth millions and immediately make the case to the IRS why you are probably going to fail. 🙃🙂

[Charles Jolley @okito]

@ChrisHarveyEsq First off this isn’t a new change. A 5 to 1 ratio in price has been common for more than a decade.

Second, the two prices are not really comparable because 409A is used for a different purpose. It is meant to determine the price you can issue options for your employees.

[Charles Jolley @okito]

@robleclerc I mean, but obviously these power demands are going to drop 100x+ due to more efficient architecture and hardware. I don’t understand the purpose of these scare tactics from people who should want everyone to buy as many gpus as possible

[Kheiron @KheironMedical]

The power of Mia® to help doctors find invasive breast cancers earlier is highlighted in @TheEconomist 's latest Tech Quarterly. Special thanks to @natashaloder for covering this important development.

https://t.co/h6MmBtdAtq

[Jack O'Meara @Jack_O_Meara]

Congrats to Peter & co at @KheironMedical on the scientific progress for breast cancer screening, and for the shoutout!

[Ty Walrod @tywalrod]

AI startups like @KheironMedical are helping spot cancer at very early stages. This is promising and will reduce suffering and save lives. ❤️